Clinical Trial Update: Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial results update for alisertib in adults with advanced nonhematological malignancies, including non-small cell lung cancer, small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastroesophageal Adenocarcinoma
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Alisertib (alisertib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Nonhematological Malignancies, Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-08-15